Sorli C - Search Results

1

Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials.

Sorli C, Warren M, Oyer D, Mersebach H, Johansen T, Gough SC. Sorli C, et al. Drugs Aging. 2013 Dec;30(12):1009-18. doi: 10.1007/s40266-013-0128-2. Drugs Aging. 2013. PMID: 24170235 Free PMC article.

2

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.

3

New developments in insulin therapy for type 2 diabetes.

Sorli C. Sorli C. Am J Med. 2014 Oct;127(10 Suppl):S39-48. doi: 10.1016/j.amjmed.2014.07.006. Am J Med. 2014. PMID: 25282012 Review.

4

Insulin therapy in type 2 diabetes: a reflection on the state of the art today and the potential journeys yet to come.

Sorli C. Sorli C. Am J Med. 2014 Oct;127(10 Suppl):S1-2. doi: 10.1016/j.amjmed.2014.07.007. Am J Med. 2014. PMID: 25282007 No abstract available.

5

The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.

Ganz ML, Li Q, Wintfeld NS, Lee YC, Sorli C, Huang JC. Ganz ML, et al. Among authors: sorli c. Curr Med Res Opin. 2015;31(9):1809-15. doi: 10.1185/03007995.2015.1074891. Epub 2015 Sep 4. Curr Med Res Opin. 2015. PMID: 26196226

6

An analysis of data management tools for diabetes self-management: can smart phone technology keep up?

Ciemins E, Coon P, Sorli C. Ciemins E, et al. Among authors: sorli c. J Diabetes Sci Technol. 2010 Jul 1;4(4):958-60. doi: 10.1177/193229681000400427. J Diabetes Sci Technol. 2010. PMID: 20663462 Free PMC article.

7

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.

Sorli C, Harashima SI, Tsoukas GM, Unger J, Karsbøl JD, Hansen T, Bain SC. Sorli C, et al. Lancet Diabetes Endocrinol. 2017 Apr;5(4):251-260. doi: 10.1016/S2213-8587(17)30013-X. Epub 2017 Jan 17. Lancet Diabetes Endocrinol. 2017. PMID: 28110911 Clinical Trial.

8

Identifying and meeting the challenges of insulin therapy in type 2 diabetes.

Sorli C, Heile MK. Sorli C, et al. J Multidiscip Healthc. 2014 Jul 2;7:267-82. doi: 10.2147/JMDH.S64084. eCollection 2014. J Multidiscip Healthc. 2014. PMID: 25061317 Free PMC article. Review.

9

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.

Pratley RE, Kang J, Trautmann ME, Hompesch M, Han O, Stewart J, Sorli CH, Jacob S, Yoon KH. Pratley RE, et al. Among authors: sorli ch. Diabetes Obes Metab. 2019 Nov;21(11):2429-2439. doi: 10.1111/dom.13824. Epub 2019 Aug 13. Diabetes Obes Metab. 2019. PMID: 31264757 Free PMC article. Clinical Trial.

10

Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.

Del Prato S, Kang J, Trautmann ME, Stewart J, Sorli CH, Derwahl M, Soto A, Yoon KH. Del Prato S, et al. Among authors: sorli ch. Diabetes Obes Metab. 2020 Jul;22(7):1176-1186. doi: 10.1111/dom.14020. Epub 2020 Apr 6. Diabetes Obes Metab. 2020. PMID: 32128957 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page